The global transrectal ultrasound devices market size was valued at USD 204.9 million in 2021 and is poised to grow at a significant CAGR of 4.6% during the forecast period 2022-28. The prostate gland is a male reproductive gland that secretes prostatic fluid (main component of semen). It surrounds the urethra immediately under the bladder and is exactly in front of the rectal wall. TRUS is a diagnostic technique that employs ultrasound to provide a picture of the prostate gland and surrounding tissues. The medical executive inserts an ultrasonic probe into the patient's rectum in this procedure. TRUS generates a picture of the prostate gland and surrounding tissue using ultrasound signals sent and received by the ultrasound probe. TRUS is used to assess whether a patient has benign prostatic hyperplasia (an enlarged prostate gland). Moreover, clinicians may prescribe TRUS when a digital rectal checkup is insufficient to detect a prostate gland abnormality.

View Detailed Report Description at 

The global transrectal ultrasound devices market segmentation:
1) By Probes: Side Fire Probes, End Fire Probes
2) By End-User: Hospitals, Diagnostic Centers, Others.

Increased incidence of benign prostatic hyperplasia and other urological abnormalities, increased cases of prostate cancer, diagnosis and treatment rates of urological abnormalities, medical care infrastructure, and product availability are driving the worldwide transrectal ultrasound device market. There are a number of additional indicators that are pointing to market expansion. Governments from all across the world are working together to guarantee early diagnosis and management of prostate cancer. This aspect, in combination with technical advancements, is expected to benefit the industry. To get reliable and exact test findings, transrectal ultrasonography or endorectal ultrasound employs a variety of technologies. 2D, 3D, and other technologies, also including real-time imaging, are among them. The emergence of such solutions is anticipated to further drive in the future years. In clinics, hospitals, diagnostic centers, and surgical centers, the use of transrectal ultrasound equipment is projected to grow. This will encourage firms to use emerging technology to create new TRUS devices.

Request sample report at                

Due to the extreme high incidence of urological illnesses, high diagnosis and treatment rates of benign prostatic hyperplasia, delivery schedules, and a strong health-care framework, North America held a significant proportion of the worldwide market. The transrectal ultrasound devices market in Spain and Italy is expected to grow rapidly in the next years, owing to improving health-care infrastructure and technical developments.

The transrectal ultrasound devices market key players Providian Medical (U.S.), Samsung (South Korea), Carestream Health (U.S.), Koninklijke Philips N.V. (Netherlands), KOELIS SA (France)

About Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747